5-phenoxypentan-2-one | 87841-90-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 5-phenoxypentan-2-one
• CAS: 87841-90-5
• 化学式: C₁₁H₁₄O₂
• 分子量: 178.231
• InChiKey: PTJYQTLCUCKWMM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-phenoxypentan-2-one 在 碳酸二乙酯 作用下， 110.0 ℃ 、17.33 kPa 条件下， 生成 6-phenoxy-3-semicarbazono-hexanoic acid ethyl ester
  参考文献：
  名称：

  New Compounds. Ethyl β-Keto-epsilon-phenoxyhexoate and Ethyl β-Keto-ζ-phenoxyheptoate

  摘要：

  DOI：

  10.1021/ja01224a055
• 作为产物：
  描述：

  (2-Phenoxy-aethyl)-hydrazin 在 氧气 作用下， 以 苯 为溶剂， 生成 5-phenoxypentan-2-one
  参考文献：
  名称：

  Hydroxyalkylation with .alpha.-hydroperoxydiazenes. Alcohols from olefins and carbonyl compounds from enol ethers

  摘要：

  DOI：

  10.1021/jo00176a023

文献信息

• Studies on the synthesis of Aspidosperma and related alkaloids. Part II. A synthetic approach to the C-21 oxygenated Aspidosperma alkaloids
  作者：Ichizo Inoue、Yoshio Ban

  DOI：10.1039/j39700000602

  日期：——

  total synthesis of (±)-aspidospermine (I) to the synthesis of (±)-limaspermine (IV). An eleven-step scheme starting from 5-phenoxypentan-2-one (XIV) gave (±)-21-phenoxyisopalosine (XXXIX), which was treated with hydrobromic acid to furnish the quaternary salt (XLII). The formation of this salt suggests that the stereochemistry of our products is not identical with that of the natural alkaloid.

  试图将（±）-aspidospermine（I）的总合成扩展到（±）-limaspermine（IV）的合成。从5-苯氧基戊烷-2-一酮（XIV）开始的十一步方案得到了（±）-21-苯氧基异palosine（XXXIX），将其用氢溴酸处理后得到季盐（XLII）。该盐的形成表明我们产品的立体化学与天然生物碱的立体化学并不相同。
• Tuning Regioselectivity of Wacker Oxidation in One Catalytic System: Small Change Makes Big Step
  作者：Kang-Fei Hu、Xiao-Shan Ning、Jian-Ping Qu、Yan-Biao Kang

  DOI：10.1021/acs.joc.8b01547

  日期：2018.9.21

  A regioselectivity switchable aerobic Wacker–Tsuji oxidation has been developed using catalytic tert-butyl nitrite as a simple organic redox cocatalyst. By solely switching the solvent, either substituted aldehydes or ketones could be prepared under mild aerobic conditions in good yields, respectively. A mechanistic explanation for the selectivity control is proposed.

  使用催化亚硝酸叔丁酯作为简单的有机氧化还原助催化剂，已经开发出了区域选择性可切换的好氧Wacker-Tsuji氧化方法。通过单独切换溶剂，可以分别在温和的需氧条件下以良好的产率制备取代的醛或酮。提出了选择性控制的机理解释。
• [EN] 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS<br/>[FR] COMPOSES 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE POUR LE TRAITEMENT DE LA TUBERCULOSE
  申请人：OTSUKA PHARMA CO LTD

  公开号：WO2005042542A1

  公开（公告）日：2005-05-12

  The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: (1)in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R1 and -(CH2)nR2 may form a spiro ring represented by the formula (30) below, together with the adjacent carbon atom (in the formula below, RRR represents a piperidyl group which may have substituents on the piperidine ring), (30)and R2 represents a benzothiazolyloxy group, quinolyloxy group, pyridyloxy group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria.

  本发明提供了一种由以下一般式表示的2,3-二氢-6-硝基咪唑[2,1-b]噁唑化合物：(1)在上述式(1)中，R1代表氢原子或C1-C6烷基，n代表0至6的整数，R1和-(CH2)nR2可以与下面的式(30)一起形成一个螺环，与相邻的碳原子一起（在下面的式中，RRR代表可能在哌啶环上具有取代基的哌啶基），(30)和R2代表苯并噻唑氧基、喹啉氧基、吡啶氧基或类似物。该化合物对结核分枝杆菌、多药耐药结核分枝杆菌和非典型耐酸细菌具有出色的杀菌作用。
• Diarylalkanoids having activity as lipoxygenase inhibitors
  申请人：Warner-Lambert Company

  公开号：US04810716A1

  公开（公告）日：1989-03-07

  The present invention is novel diarylalkanoids having activity as lipoxygenase inhibitors, novel pharmaceutical compositions therefor, and novel methods of use in treating asthma, allergies, cardiovascular diseases, migraines, psoriasis and immunoinflammatory diseases for diarylalkanoids. The compounds of this invention are also useful as cytoprotective agents.

  本发明涉及作为脂氧合酶抑制剂的新型二芳基烷酮类化合物，以及用于治疗哮喘、过敏、心血管疾病、偏头痛、牛皮癣和免疫炎症性疾病的新型药物组合物和使用方法。本发明的化合物还可用作细胞保护剂。
• Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds
  申请人：Kshirsagar A. Tushar

  公开号：US20070167476A1

  公开（公告）日：2007-07-19

  Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds (i.e., imidazoquinolines, tetrahydroimidazoquinolines, imidazonaphthyridines, tetrahydroimidazonaphthyridines, and imidazopyridines), pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.

  本文介绍了哌嗪、[1,4]二氮杂辛烷、[1,4]二氮杂庚烷和[1,5]二氮杂庚烷融合的咪唑环化合物（即咪唑喹啉、四氢咪唑喹啉、咪唑萘啉、四氢咪唑萘啉和咪唑吡啶），以及含有这些化合物的制药组合物、中间体、制备方法和用于动物中诱导或抑制细胞因子生物合成以及治疗包括病毒和肿瘤疾病在内的疾病的方法。